A new bill would give providers more discretion in what medical conditions could qualify a patient for medical cannabis.
A new bill would give providers more discretion in what medical conditions could qualify a patient for medical cannabis.
New data from Quest Diagnostics 2024 Drug Testing Index, and industry leaders discuss how rescheduling will impact workers’ comp.
While bureaucratic wheels may take time, marijuana will become a Schedule III drug soon.
With many federal agencies in alignment, the ultimate decision rests with the DEA.
A recent proclamation applies to simple federal possession charges on or before December 22, 2023.
Similar to a Washington law passed earlier this year, employees are not permitted to possess, to be impaired by, or to use cannabis on the job.
A new study uses data from 583,000 group health patients with chronic noncancer pain.
As other states come closer to recreational legalization, Washington State pushes the needle further.
Three states have introduced bills or seen court cases overturned in relation to this policy.
New reports from the Journal of the American Medical Association and Health Economics.
